ResearcherChang Gung UniversityNo recent work listed
Chih-Po Hsu
Matched on ORCID iD 0000-0002-4737-2800; OpenAlex author ID A5079492105. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance. Co-author DOI 10.3390/ijms24087331↗
- Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center. Co-author DOI 10.1016/j.asjsur.2016.11.009↗
- CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery. Co-author DOI 10.21873/invivo.11411↗
- Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. First author DOI 10.1097/md.0000000000004191↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tsann‐Long Hwang · 4 shared papers, 2016–2023 · strength 0.46
- Paper Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance. DOI 10.3390/ijms24087331↗
- Paper Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in … DOI 10.1016/j.asjsur.2016.11.009↗
- Paper CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery. DOI 10.21873/invivo.11411↗
- Yu-Chi Kuo · 1 shared paper, 2023 · strength 0.24
- Chun‐Nan Yeh · 3 shared papers, 2016–2018 · strength 0.22
- Paper Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in … DOI 10.1016/j.asjsur.2016.11.009↗
- Paper CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery. DOI 10.21873/invivo.11411↗
- Paper Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. DOI 10.1097/md.0000000000004191↗
- Keng-Hao Liu · 1 shared paper, 2016 · strength 0.06
- Shih-Chun Chang · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.